(Q35820303)

10 August 2017

1 reference

title

What place does naltrexone have in the treatment of alcoholism? (English)

1 reference

10 August 2017

0 references

0 references

Damaris J Rohsenow

1

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

18

1 reference

10 August 2017

issue

9

1 reference

10 August 2017

page(s)

547-560

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200418090-00001

10 August 2017

exact match

0 references

cites work

Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study

1 reference

12 December 2020

Clinical trials in psychiatry: should protocol deviation censor patient data?

1 reference

12 December 2020

Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching.

1 reference

12 December 2020

Sustained-release naltrexone for alcoholism treatment: a preliminary study

1 reference

12 December 2020

Naltrexone and alcohol dependence. Role of subject compliance

1 reference

12 December 2020

Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence

1 reference

12 December 2020

Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes

1 reference

12 December 2020

Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study

1 reference

12 December 2020

Naltrexone for alcohol dependence: a randomized controlled trial

1 reference

12 December 2020

Current problems and future challenges in randomized clinical trials

1 reference

12 December 2020

Naltrexone-induced alterations in human ethanol intoxication.

1 reference

12 December 2020

A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence

1 reference

12 December 2020

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

12 December 2020

Predicting treatment response to naltrexone: the influence of craving and family history

1 reference

12 December 2020

Naltrexone in the treatment of alcohol dependence

1 reference

12 December 2020

Naltrexone in the treatment of alcoholism: a clinical review

1 reference

12 December 2020

Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting

1 reference

12 December 2020

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

12 December 2020

Naltrexone increases the latency to drink alcohol in social drinkers.

1 reference

12 December 2020

Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods

1 reference

12 December 2020

Six-month follow-up of naltrexone and psychotherapy for alcohol dependence

1 reference

12 December 2020

A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence

1 reference

12 December 2020

A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial

1 reference

12 December 2020

Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction

1 reference

12 December 2020

Effects of naltrexone on alcohol self-administration in heavy drinkers.

1 reference

12 December 2020

Naltrexone's effects on reactivity to alcohol cues among alcoholic men.

1 reference

12 December 2020

Naltrexone's effect on cue-elicited craving among alcoholics in treatment.

1 reference

12 December 2020

Cue exposure with coping skills training and communication skills training for alcohol dependence: 6- and 12-month outcomes

1 reference

12 December 2020

Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.

1 reference

12 December 2020

Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial

1 reference

12 December 2020

Effect of naltrexone on alcohol "high" in alcoholics.

1 reference

12 December 2020

The DRD4 VNTR polymorphism moderates craving after alcohol consumption

1 reference

12 December 2020

Naltrexone and relapse prevention treatment for cocaine-dependent patients

1 reference

12 December 2020

Naltrexone in the treatment of alcohol dependence

1 reference

12 December 2020

A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse

1 reference

12 December 2020

Predictors of compliance with naltrexone among alcoholics.

1 reference

12 December 2020

10.2165/00023210-200418090-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

1008900969

0 references

1 reference